Travere Therapeutics, Inc. (TVTX) stock
TVTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/30751% above fair value
$50.24−0.86 (-1.68%)
Close on Nov 18, 2026Market cap $4.74BP/E –Yield –
Travere Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Travere Therapeutics's market cap was $4.90B on Nov 11, 2026, against $3.17B a year earlier. Over the last 5 years it ranged from $416.78M to $6.24B, with a median of $1.48B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $4.90B | +43.4% |
| 2025 | Dec 31, 2025 | $3.42B | +151.9% |
| 2024 | Dec 31, 2024 | $1.36B | +101.0% |
| 2023 | Dec 29, 2023 | $675.25M | -49.9% |
| 2022 | Dec 30, 2022 | $1.35B | -28.8% |
| 2021 | Dec 31, 2021 | $1.89B | +36.2% |
| 2020 | Dec 31, 2020 | $1.39B | +128.0% |
| 2019 | Dec 31, 2019 | $610.01M | -34.5% |
| 2018 | Dec 31, 2018 | $931.63M | +12.6% |
| 2017 | Dec 29, 2017 | $827.64M | +16.0% |
| 2016 | Dec 30, 2016 | $713.74M | +2.8% |
| 2015 | Dec 31, 2015 | $694.60M | +115.6% |
| 2014 | Dec 31, 2014 | $322.16M | +150.4% |
| 2013 | Dec 31, 2013 | $128.63M | +35888.9% |
| 2012 | Dec 31, 2012 | $357.43K | – |
See a number that looks wrong?